Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease

Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee

(2014) Frank M Ruemmele et al.   GUT

Meta-analysis

(2014) Jin-Feng Lin et al.   INFLAMMATORY BOWEL DISEASES

The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

(2014) Kaija-Leena Kolho et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The Diagnostic Accuracy of Fecal Calprotectin During the Investigation of Suspected Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

(2013) Paul Henderson et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Diagnostics and Prognostics of Inflammatory Bowel Disease with Fecal Neutrophil-Derived Biomarkers Calprotectin and Lactoferrin

(2013) Taina Sipponen   DIGESTIVE DISEASES

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Fecal Calprotectin Levels Predict the Clinical Course in Patients With New Onset of Ulcerative Colitis

(2013) Anders Lasson et al.   INFLAMMATORY BOWEL DISEASES

Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy

(2013) Martine De Vos et al.   INFLAMMATORY BOWEL DISEASES

Therapeutic Drug Monitoring of Infliximab and Mucosal Healing in Inflammatory Bowel Disease

(2013) Stephane Paul et al.   INFLAMMATORY BOWEL DISEASES

Optimising monitoring in the management of Crohn's disease: A physician's perspective

(2013) Pavol Papay et al.   Journal of Crohns & Colitis

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic accuracy and clinical application of faecal calprotectin in adult patients presenting with gastrointestinal symptoms in primary care

(2013) Polychronis Pavlidis et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Evaluation of Prevent ID and Quantum Blue rapid tests for fecal calprotectin

(2012) Jan Hessels et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Fecal Calprotectin in Pediatric Inflammatory Bowel Disease: A Systematic Review

(2012) Ioannis D. Kostakis et al.   DIGESTIVE DISEASES AND SCIENCES

Limitations of Fecal Calprotectin At Diagnosis in Untreated Pediatric Crohnʼs Disease

(2012) Ron Shaoul et al.   INFLAMMATORY BOWEL DISEASES

Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

(2012) Patrick F. van Rheenen   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin concentration predicts outcome in inflammatory bowel disease after induction therapy with TNFα blocking agents

(2012) Pauliina Molander et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin in predicting relapse of inflammatory bowel diseases: A meta-analysis of prospective studies

(2012) Ren Mao et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease

(2012) Geert DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

P274 Close monitoring of CRP and fecal calprotectin levels to predict relapse in Crohn's disease patients. A sub-analysis of the STORI study

(2012) N. de Suray et al.   Journal of Crohns & Colitis

Rapid Test for Fecal Calprotectin Levels in Children With Crohn Disease

(2012) KL Kolho et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Surrogate markers and clinical indices, alone or combined, as indicators for endoscopic remission in anti-TNF-treated luminal Crohn's disease

(2012) Clas-Göran af Björkesten et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Prediction of Crohn’s disease relapse with faecal calprotectin in infliximab responders: a prospective study

(2011) D. Laharie et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers

(2011) Alain M. Schoepfer et al.   Journal of Crohns & Colitis

Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis

(2011) M. De Vos et al.   Journal of Crohns & Colitis

Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels

(2011) Anssi Hämäläinen   WORLD JOURNAL OF GASTROENTEROLOGY

Fecal calprotectin is a predictive marker of relapse in Crohnʼs disease involving the colon: a prospective study

(2010) Lamia Kallel et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring response

(2010) D. Turner et al.   GUT

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

(2010) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Predicts the Clinical Course of Acute Severe Ulcerative Colitis

(2009) G T Ho et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Faecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn's disease

(2009) C. A. Lamb et al.   BRITISH JOURNAL OF SURGERY

Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis

(2009) Matt W. Johnson et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis†

(2009) Mikko P. Pakarinen et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin variability in Crohnʼs disease

(2009) Bjrn Moum et al.   INFLAMMATORY BOWEL DISEASES

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

(2009) Valle García-Sánchez et al.   Journal of Crohns & Colitis

Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings

(2008) T. SIPPONEN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?

(2008) Renata D'Incà et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome

(2008) Charlotte M.T. Otten et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease

(2008) Dorota Walkiewicz et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases

(2008) A. Damms et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Fecal calprotectin: assessment of a rapid test

(2008) T. A. Vestergaard et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies

(2007) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity assessed by fecal calprotectin and lactoferrin: Correlation with Crohnʼs disease activity index and endoscopic findings

(2007) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES